CAS: 1338824-20-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 4(1H)-Quinazolinone,2-[3-[(2,6-dimethylphenoxy)methyl]-4-methoxyphenyl]-2,3-dihydro-3-(3-pyridinylmethyl)- REF: IN-DA01XAN6CAS: 1338824-20-6 | 98% | To inquire | Wed 27 Nov 24 |
 | NCGC00229600 REF: TM-T12192CAS: 1338824-20-6 | 99.27% | 62.00 €~2,759.00 € | Wed 29 Jan 25 |
4(1H)-Quinazolinone,2-[3-[(2,6-dimethylphenoxy)methyl]-4-methoxyphenyl]-2,3-dihydro-3-(3-pyridinylmethyl)-
CAS:1338824-20-6
Formula:
C30H29N3O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
479.5696
Ref: IN-DA01XAN6
| 1mg | 147.00 € | ||
| 5mg | 578.00 € | ||
| 10mg | 612.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 27 Nov 2024
NCGC00229600
CAS:1338824-20-6
NCGC00229600: Allosteric inverse TSHR agonist; blocks TSH and antibody TSHR activation; for Graves' disease research.
Formula:
C30H29N3O3
Purity:
99.27%
Color and Shape:
Solid
Molecular weight:
479.57
Ref: TM-T12192
| 1mg | 62.00 € | ||
| 5mg | 141.00 € | ||
| 10mg | 205.00 € | ||
| 25mg | 360.00 € | ||
| 50mg | 542.00 € | ||
| 100mg | 819.00 € | ||
| 200mg | 1,082.00 € | ||
| 1mL*10mM (DMSO) | 148.00 € |
Estimated delivery in United States, on Wednesday 29 Jan 2025
